Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2562 (109th)

Preservation of Antibiotics for Medical Treatment Act of 2005

referredUnited States· United States Congress· EN

Introduced

24 May 2005

Last action

3 June 2005 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Sen. Brown, Sherrod [D-OH], Rep. Pallone, Frank [D-NJ-6], Rep. Kaptur, Marcy [D-OH-9], Rep. Allen, Thomas H. [D-ME-1], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Sabo, Martin Olav [D-MN-5], Rep. Sherman, Brad [D-CA-32], Rep. Abercrombie, Neil [D-HI-1], Rep. Stark, Fortney Pete [D-CA-13], Rep. Filner, Bob [D-CA-51], Rep. Waxman, Henry A. [D-CA-33], Rep. Wexler, Robert [D-FL-19], Rep. Honda, Michael M. [D-CA-15], Rep. Berman, Howard L. [D-CA-28], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Conyers, John, Jr. [D-MI-13]

Subjects

Healthcare

Source updated

15 August 2025

Healthcare

Summary

Preservation of Antibiotics for Medical Treatment Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms. Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met. Requires the manufacturer of such a drug or an animal feed for food-producing animals containing such a drug to report sales information to the Secretary.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 24 May 2005

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 24 May 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 24 May 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 3 June 2005

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 24 May 2005

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 24 May 2005

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 24 May 2005

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.